GLP-1 Maintenance Dose: What Dose Do You Stay On After Weight Loss?
There is no single GLP-1 maintenance dose — and that's the honest answer most pages dance around.
Your long-term dose depends on which medication you take, what the FDA-approved label allows, how your body responds, your side effects, and your prescriber's judgment. Quick version, verified : the Wegovy pen maintenance dose is 1.7 mg or 2.4 mg once a week. The Wegovy pill is 25 mg once a day. Zepbound is 5, 10, or 15 mg once a week. The new Foundayo pill is 5.5–17.2 mg once a day. None of these match the diabetes-drug doses for Ozempic, Mounjaro, or Rybelsus — and 2.5 mg Zepbound is a starter dose, not a maintenance dose, whatever you may have read.
Fast answers: find your question below
| If you're asking… | The fast answer | Section on this page |
|---|---|---|
| “What is a maintenance dose?” | The steady dose you stay on after the slow build-up phase. Not always the lowest, not always the highest. | What is a GLP-1 maintenance dose? |
| “What's my drug's maintenance dose?” | It depends on the medication. Use the chart or the interactive lookup. | The maintenance dose for every GLP-1 |
| “Can I go lower after I hit my goal?” | Sometimes -- but a lower dose protects your weight loss less well than your full dose. | Can you lower your dose? |
| “Can I just stop?” | Most people regain a large share of the weight after stopping. | What happens if you stop? |
| “Is 2.5 mg Zepbound my maintenance dose?” | No. 2.5 mg is the starter dose, not a maintenance dose. | Zepbound maintenance dose |
| “Will insurance keep paying for it?” | Maybe -- many plans want proof you reached and held a result. | How insurance treats maintenance |
Free 60-second tool. Turns your medication, current dose, and biggest worry into a prescriber-ready checklist.
About this guide
We're The RX Index — a pricing intelligence and comparison resource for GLP-1 telehealth providers. We built this guide from official sources, not internet rumor.
The RX Index may earn a commission if you use some of the provider links on this page. That never changes our dosing guidance, which comes straight from official labels, FDA communications, payer policies, and published studies.
What we actually checked:
- The FDA-approved weight-management dosing for Wegovy pen, Wegovy tablets, Zepbound, Foundayo, and Saxenda — straight from the prescribing information.
- The diabetes-product dosing for Ozempic (injection and the new pill), Mounjaro, and Rybelsus — so you don't mix up diabetes doses with weight-loss maintenance doses.
- Which doses are starter or build-up doses, not maintenance doses.
- FDA warnings about dosing mistakes with compounded semaglutide and tirzepatide.
- Real trial data: STEP 1, SURMOUNT-4, and the 2026 SURMOUNT-MAINTAIN trial in The Lancet.
- Current insurance rules, including the new Medicare GLP-1 Bridge.
This is general information to help you have a better conversation with your prescriber. It is not medical advice and does not replace your doctor.
What is a GLP-1 maintenance dose?
A GLP-1 maintenance dose is the steady dose your prescriber keeps you on for the long run, after the slow “work-up” phase is over. It's the dose meant to hold your results — your weight, your appetite, your health markers. It is not automatically the lowest dose, and it is not automatically the highest dose. The right one depends on the medication's label, how you respond, and what side effects you can live with.
GLP-1 medications all start low on purpose. The first dose isn't there to drive weight loss — it's there to let your body get used to the drug with as little nausea as possible. Then you step up, usually every four weeks, until you reach a dose that works for you without rough side effects. That dose is your maintenance dose.
Starter vs. build-up vs. maintenance vs. max — they're not the same
Mixing these up is the most common mistake we see:
| Dose type | What it means | Example |
|---|---|---|
| Starter dose | The first, lowest dose. Helps your body adjust. Not a treatment dose. | Zepbound 2.5 mg, Wegovy pen 0.25 mg |
| Build-up dose | The step-up doses on the way up. Each held about 4 weeks. | Wegovy pen 0.5 mg, 1 mg; Zepbound 7.5 mg |
| Maintenance dose | The dose you stay on long-term once you've finished stepping up. | Wegovy pen 1.7 or 2.4 mg; Zepbound 5/10/15 mg |
| Maximum dose | The highest dose the label allows. Not a personal goal -- and not always your maintenance dose. | Zepbound 15 mg; Foundayo 17.2 mg |
The maintenance dose for every GLP-1 (the chart)
Every number comes from the official prescribing information or manufacturer dosing page, checked on the date below. Use this to find the label range for your medication, then bring it to your prescriber.
| Medication | FDA status | Starter dose | Build-up | Maintenance dose | What's NOT maintenance | Route / timing |
|---|---|---|---|---|---|---|
| Wegovy pen (semaglutide) | weight | 0.25 mg/wk × 4 wks | 0.5 → 1 → 1.7 → 2.4 mg, ~4 wks each | 1.7 mg or 2.4 mg once weekly | 0.25, 0.5, 1 mg are build-up doses | Weekly shot |
| Wegovy pill (semaglutide) | weight (Dec 2025) | 1.5 mg/day × 30 days | 1.5 → 4 → 9 → 25 mg | 25 mg once daily | 1.5, 4, 9 mg are build-up doses | Daily pill; morning, empty stomach, water ≤4 oz, wait ≥30 min |
| Zepbound (tirzepatide) | weight | 2.5 mg/wk × 4 wks | +2.5 mg every ~4 wks | 5, 10, or 15 mg once weekly | 2.5 mg is the starter, NOT maintenance | Weekly shot |
| Foundayo (orforglipron) | weight (Apr 2026) | 0.8 mg/day × 30 days | 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 mg, ~30 days each | 5.5, 9, 14.5, or 17.2 mg once daily (max 9 mg with strong CYP3A4 inhibitor) | 0.8 and 2.5 mg are build-up doses | Daily pill; any time, with or without food |
| Saxenda (liraglutide) | weight | 0.6 mg/day, week 1 | 0.6 → 1.2 → 1.8 → 2.4 → 3 mg, weekly | 3 mg once daily | 0.6-2.4 mg are build-up doses | Daily shot |
| Ozempic injection (semaglutide) | diabetes | 0.25 mg/wk × 4 wks | 0.5 → 1 → 2 mg | 0.5, 1, or 2 mg once weekly (for blood sugar) | 0.25 mg is the starter | Weekly shot |
| Ozempic pill (oral semaglutide) | diabetes (May 2026) | 1.5 mg/day × 30 days | 1.5 → 4 → 9 mg | 4 or 9 mg once daily (for blood sugar) | 1.5 mg is the starter | Daily pill; morning, empty stomach |
| Mounjaro (tirzepatide) | diabetes | 2.5 mg/wk × 4 wks | +2.5 mg every ~4 wks up to 15 mg | 5-15 mg once weekly (for blood sugar) | 2.5 mg is the starter | Weekly shot |
| Rybelsus (oral semaglutide) | diabetes (older formula) | 3 mg/day × 30 days | 3 → 7 → 14 mg | 7 or 14 mg once daily (for blood sugar) | 3 mg is the starter | Daily pill; morning, empty stomach |
| Compounded semaglutide/tirzepatide | NOT FDA-approved | Varies by pharmacy | Varies; often a vial you measure yourself | No standard dose | Every dose is non-standardized | Usually vial + syringe |
Sources: manufacturer prescribing information and dosing pages; FDA labels and DailyMed. Last verified .
Interactive GLP-1 Maintenance Dose Lookup
Pick your medication to see the build-up ladder, maintenance dose, missed-dose rule, and key interactions. For information only — bring results to your prescriber.
Drug-by-drug maintenance dose details
Wegovy pen maintenance dose
The Wegovy pen (once-weekly semaglutide shot for weight) has two approved maintenance doses: 1.7 mg or 2.4 mg once a week. The build-up runs 0.25 → 0.5 → 1 → 1.7 → 2.4 mg, four weeks per step, reaching 2.4 mg in about 16 weeks if you tolerate it. Many people stay at 2.4 mg long-term, but 1.7 mg is also an approved maintenance dose if 2.4 mg is too much. There's also a higher Wegovy HD 7.2 mg option, approved March 2026 for adults who tolerate 2.4 mg and need more weight-loss support.
Wegovy pill maintenance dose
The Wegovy pill (oral semaglutide for weight) builds up to a maintenance dose of 25 mg once a day. The catch is timing: take it in the morning on an empty stomach with water (up to 4 ounces), then wait at least 30 minutes before eating, drinking anything else, or taking other pills. Miss that window and it doesn't absorb well. For some people, that daily routine is the deciding factor between a pill and a weekly shot.
Zepbound maintenance dose
Zepbound (once-weekly tirzepatide shot for weight) has three approved maintenance doses: 5 mg, 10 mg, or 15 mg once a week. You start at 2.5 mg for four weeks — that's a starter dose, not a maintenance dose, no matter how often you see “2.5 mg” mentioned online. From there your prescriber raises by 2.5 mg every four weeks or more, up to a maximum of 15 mg. The label is clear: if a dose is too hard on you, your prescriber can keep you at a lower maintenance dose rather than pushing to the max.
Foundayo maintenance dose
Foundayo (orforglipron) — the first GLP-1 pill that's a small, non-peptide molecule — was FDA-approved in April 2026 for weight. It starts at 0.8 mg once a day and steps up about every 30 days through 2.5 mg, 5.5 mg, and on to 9 mg, 14.5 mg, or 17.2 mg. Maintenance usually settles at 5.5, 9, 14.5, or 17.2 mg once daily.
- The max drops to 9 mg/day if you take a strong CYP3A4 inhibitor (like ketoconazole or certain HIV drugs) — not a footnote you want to miss.
- Unlike Wegovy pill, Foundayo can be taken any time of day, with or without food.
- Miss 7 or more days in a row and your prescriber will likely restart you at a lower dose.
Saxenda maintenance dose
Saxenda (liraglutide) is the older, daily-shot option. It builds up weekly — 0.6 → 1.2 → 1.8 → 2.4 → 3 mg — and 3 mg once a day is both the maintenance dose and the max. The honest downside: it's a shot every day, where most newer drugs are once a week. For many people, that's reason enough to ask about a weekly option instead.
Ozempic, Mounjaro, and Rybelsus: an important note
Ozempic, Mounjaro, and Rybelsus are FDA-approved for type 2 diabetes, not for weight loss. Their doses are set for blood sugar, not weight management.
A 2026 update makes this confusing: Novo Nordisk now sells two Ozempic products — the familiar weekly shot (up to 2 mg) and a new once-daily Ozempic pill (1.5 → 4 → 9 mg) launched May 2026, taking the place of Rybelsus. All of these are diabetes medicines. Some share an active ingredient with a weight-loss drug — Ozempic and Rybelsus contain semaglutide, like Wegovy; Mounjaro contains tirzepatide, like Zepbound. But the formulations, doses, and labels are not interchangeable.
If you're using Ozempic or Mounjaro for weight management, the doses in the chart are for blood sugar, not weight loss — your prescriber manages those specifics.
Can you lower your GLP-1 dose after you reach your goal?
Sometimes — but this should be a prescriber-guided decision, not a solo experiment, because a lower dose protects your weight loss less well than staying on your full dose. The good news from the newest research: dropping to a lower dose still beat stopping by a wide margin.
SURMOUNT-MAINTAIN — published in The Lancet, May 12, 2026
The first big trial designed specifically to test what happens when you lower your dose after losing weight. 441 adults on tirzepatide; 378 who lost at least 5% were split three ways for a year. Here's where each group landed at week 112:
| Group | What they did | Weight change at week 112 |
|---|---|---|
| Full dose | Stayed on 10-15 mg | −21.9% (kept losing) |
| Lower dose | Dropped to 5 mg | −16.6% (held most of loss) |
| Stopped | Switched to placebo | −9.9% (regained a big chunk) |
People who stayed on the full dose were about 7x more likely to maintain their weight loss than those who stopped. People who dropped to 5 mg were about 4x more likely to maintain it than those who stopped. Lower dose is a real option — but full-dose maintenance preserved the most.
Your four maintenance paths
| Path | Who it might fit | What to ask your prescriber |
|---|---|---|
| Stay at your current dose | Weight is stable, side effects are fine, coverage is steady | "If this is working, is there any reason to change it?" |
| Step down to a lower dose | Side effects are bugging you, still losing too fast, or cost is a strain | "What lower dose is still appropriate for me?" |
| Stretch the time between doses | Cost or refill timing is the problem | "Is spacing my doses safe for my medication and my situation?" |
| Stop with monitoring | Pregnancy plans, a safety issue, or your clinician's call | "What weight regain or symptom should make me call you?" |
The smart move isn't picking a number off the internet. It's bringing your weight trend, your side effects, and your real goal to the person who can actually weigh those tradeoffs with you.
Can you take a GLP-1 every other week or stretch your doses?
Officially, no — the labels set a daily or weekly schedule, and stretching doses on your own can let your appetite and “food noise” come roaring back before your next dose. Some prescribers do discuss spacing in specific situations, usually for cost or side-effect reasons. But “every other week” is a question for your clinician, not a do-it-yourself maintenance plan.
If cost or side effects are pushing you toward spacing, that's worth saying out loud to your prescriber. A better-fitting dose, or a different program, usually beats an informal spacing plan that your pharmacy and insurance refills aren't built around.
Is GLP-1 microdosing the same as maintenance dosing?
No. “Microdosing” — using a dose lower than any approved dose — is not an official, FDA-recognized way to take these drugs. There are lower approved maintenance doses (like Wegovy pen 1.7 mg), and your prescriber can choose one. But going below the labeled doses is a clinical decision with limited evidence, and it's especially risky with compounded products, where the strength can vary and the FDA has warned about dosing mistakes. Ask your prescriber rather than improvising.
What if you miss doses during maintenance?
Missed-dose rules are different for each medication. A short gap usually isn't a crisis — semaglutide and tirzepatide stay in your body for about a week — but doubling up to “catch up” can pile on side effects. If you've missed several weekly doses in a row, don't just restart at your old dose — call your prescriber.
| Medication | Missed-dose rule (from the label) |
|---|---|
| Wegovy pen (weekly) | If your next dose is >2 days away, take the missed dose now. If <2 days, skip it and inject on your normal day. Never two shots in one week. |
| Wegovy pill / Ozempic pill / Rybelsus / Foundayo (daily) | Skip the missed pill and take the next one as usual the following day. Don't take two in one day. For Foundayo specifically: if you miss 7 or more days in a row, your prescriber will likely restart you at a lower dose. |
| Zepbound and Mounjaro (weekly) | If ≤4 days (96 hours) since the missed dose, take it. If more than 4 days, skip it and resume your normal schedule. |
| Ozempic injection (weekly) | Can be taken within 5 days (120 hours) of the missed day. After 5 days, skip it. |
What happens if you stop taking a GLP-1 after weight loss?
Most people regain a large share of their lost weight after stopping a GLP-1, though how much and how fast varies. Here's the evidence:
Semaglutide — STEP 1 follow-up
After people stopped Wegovy 2.4 mg and the lifestyle program, they regained about two-thirds of their lost weight over the next year. Their blood pressure and other markers drifted back toward where they started. Still: nearly half held onto a 5%-or-better loss.
Tirzepatide — SURMOUNT-4
People who stopped tirzepatide regained much of their weight, while those who kept taking it held their loss and kept going. The group that continued lost roughly 5.5% more, while the group switched to placebo regained about 14% of their body weight.
How do you know your GLP-1 maintenance dose is working?
A maintenance dose is “working” when your weight, appetite, side effects, and health markers are steady enough to keep going — not necessarily when you're still losing. Maintenance success means holding your result without creating a new problem. A little hunger is normal; the goal is durable control, not zero appetite.
| Track each week | Why it matters |
|---|---|
| Weight trend | One weigh-in is noise. The direction over a few weeks is the real signal. |
| Waist measurement | Helps tell water-weight wobble apart from real change. |
| Food noise / cravings | These often creep back before the scale moves. |
| Protein + any strength training | Helps protect muscle while your weight is stable. |
| Side effects | Ongoing nausea or other issues are worth a dose conversation. |
| Refill timing | Running out by accident can force an unplanned stop. |
| Coverage status | Some plans want documentation to keep paying. |
What should you ask your prescriber before changing your GLP-1 maintenance dose?
Before you change anything, bring your prescriber a clear picture: your current dose, your weight trend, your side effects, your refill situation, and your coverage. The most useful question isn't “Can I go lower?” It's “What maintenance plan gives me the best balance of keeping the weight off, feeling okay, and being able to afford it?”
Screenshot this before your visit:
- Is my current dose a starter, a build-up dose, or a maintenance dose?
- Am I at a label maintenance dose for my specific medication?
- What would make you keep me where I am?
- What would make you lower my dose?
- What would make you raise it again, or go back up?
- Is spacing out my doses safe for my drug and my health?
- How much weight regain should make me call you?
- Should I be tracking labs, waist, or blood pressure?
- How do I protect my muscle during maintenance?
- Will my insurance need paperwork to keep covering this?
- What do I do if I miss doses or can't refill on time?
- If I switch from a shot to a pill, what changes?
How insurance treats GLP-1 maintenance dosing
Whether your plan keeps paying often depends on proving the drug is working. Many insurers want to see that you reached a stable maintenance dose and hit (or held) a weight-loss target before they'll renew coverage. This is where people get blindsided at the pharmacy counter.
| Plan / program | What it can take to KEEP coverage | Good to know |
|---|---|---|
| Aetna (commercial) | About 3 months at a stable maintenance dose plus 5% weight loss -- or a 6-month weight-management program first | Needs prior authorization |
| CVS Caremark | Varies by plan; has required holding about a 5% loss | Coverage is shifting fast -- CVS restored Zepbound coverage May 2026; check your specific plan |
| Cigna (one formulary policy) | Continue if you've lost at least 5% | Varies by plan |
| Medicaid (state programs) | Varies a lot by state, and changing | California's Medi-Cal dropped Wegovy, Zepbound, and Saxenda for weight loss as of Jan 1, 2026 (with narrow exceptions). Verify your state. |
| Medicare Part D | Generally not covered for weight loss alone | See the new Medicare GLP-1 Bridge below |
The Medicare GLP-1 Bridge (new — starts July 1, 2026)
Medicare has long left out drugs used only for weight loss. That changes, at least temporarily: eligible Part D members can get certain GLP-1s for a flat $50 a month for weight management, from July 1, 2026 through December 31, 2027. Drugs included: all formulations of Foundayo, all formulations of Wegovy, and the Zepbound KwikPen.
- The Bridge runs outside the normal Part D benefit — your $50 won't count toward your deductible or out-of-pocket max, and the usual low-income subsidy doesn't apply.
- Eligibility is based on prior-authorization rules tied to your BMI and health conditions.
- If you already qualify for a GLP-1 through Part D for diabetes, sleep apnea, or MASH, you'll get it the regular way — not through the Bridge.
To keep maintenance coverage, it helps to have your starting weight, your current weight, how long you've been at your dose, your side effects, and your prescriber's notes ready before each renewal.
One honest thing about getting brand-name coverage help: if your only goal is the rock-bottom cash price, Ro is not the cheapest door — Ro's GLP-1 program is built around FDA-approved medication rather than cheaper compounded versions. If price is your single priority, our GLP-1 cost guide shows cheaper routes. But because Ro sticks to FDA-approved medications and runs a free GLP-1 Insurance Coverage Checker — and helps with the prior-authorization paperwork — you get a predictable, label-set dose and real help working your plan. For people trying to stay on Zepbound or Foundayo through insurance, that support can be the difference between a smooth refill and a denial.
Ro's free GLP-1 Insurance Coverage Checker. Best fit if you want to check coverage for an FDA-approved brand like Zepbound or Foundayo. Coverage isn't guaranteed and depends on your plan.
How much does GLP-1 maintenance cost?
Maintenance is not automatically cheaper than losing the weight in the first place. Your cost depends on the medication, the dose, your insurance, any cash-pay program, refill timing, and whether you're using an FDA-approved brand or a compounded version. A few things to know:
- The same dose can continue indefinitely, so the monthly cost can keep going as long as you do.
- With some cash-pay programs, higher maintenance doses cost more than lower ones.
- If your insurance paperwork lapses, coverage can stop even if it was approved before.
- A telehealth membership fee can be separate from the medication price — “the price” might be two numbers, not one.
- Cutting cost by stretching doses on your own can backfire (see above).
For a sense of scale as of mid-2026: eligible Medicare members can use the new Bridge at $50/month; Foundayo self-pay starts around $149/month for the lowest dose; and some telehealth programs advertise low intro pricing that rises after the first month. Numbers like these move constantly — treat any price you see as “verify before you buy.”
- → GLP-1 cost without insurance
- → Wegovy cost without insurance
- → Zepbound cost without insurance
- → Foundayo cost without insurance
- → Best brand-name GLP-1 telehealth providers
Is compounded GLP-1 maintenance dosing different?
FDA safety warning — the most important safety point on this page
Compounded GLP-1 medicines are not FDA-approved, which means the FDA hasn't reviewed them for safety, effectiveness, or quality. The FDA has warned about dosing mistakes with compounded semaglutide and tirzepatide — including people accidentally taking far more than intended. Many compounded products come in multi-dose vials you fill yourself, and the strength can differ between pharmacies. The FDA has reported people taking 5 to 20 times their intended dose, often from confusion between “milligrams,” “milliliters,” and “units.” Overdoses have led to severe nausea and vomiting, dehydration, low blood sugar, and hospital stays.
Some compounded products also use a different salt form — the FDA says semaglutide sodium and semaglutide acetate are different active ingredients from the semaglutide in approved medicines, and it isn't aware of a lawful basis for using them in compounding.
If you do use a compounded medication, these are the questions to ask — not for a dose, but for safety:
- "What's the exact strength, in milligrams per milliliter?"
- "How many units equals my prescribed dose?"
- "Can you show me the mark on the syringe?"
- "Is this semaglutide base, or a salt form?"
- "Which pharmacy compounds this, and is it a 503A or 503B pharmacy?"
- "What do I do if I miss a dose, or accidentally take too much?"
- "Who do I call after hours if I have severe symptoms?"
If you'd rather move to a product where the dose is set for you, our provider comparison lays out medication source, pharmacy details, pricing, and cancellation terms side by side.
When should you NOT lower or stop your dose on your own?
Never change your GLP-1 dose on your own if any of these apply:
- You have type 2 diabetes or take blood-sugar medication.
- You're pregnant, trying to conceive, or breastfeeding.
- You have severe nausea, vomiting, dehydration, or bad belly pain.
- You have a history or symptoms of gallbladder disease or pancreatitis.
- You have surgery or anesthesia coming up.
- You have an eating-disorder history or are losing weight very fast.
- You're not sure of your compounded product's strength or syringe marks.
- You've missed doses or had a long refill gap.
- You're switching between a shot and a pill.
- You're combining more than one weight-loss medication.
Which GLP-1 maintenance path fits your situation?
| Your situation | What it might mean | Best next step |
|---|---|---|
| At goal, stable, feeling fine | Your plan may already be working | Ask if staying at your current dose is right |
| At goal but still losing fast | Dose may be strong, or you may need more food/protein | Call your prescriber before changing anything |
| Cravings (food noise) creeping back | Could be dose, sleep, stress, or a missed dose | Track the pattern and ask about adjusting |
| Regaining weight | Worth a real evaluation, not a guess | Bring your weight trend and dose history |
| Side effects won't quit | Lowering, slowing down, or switching may help | Ask which side effects are okay vs. warning signs |
| Insurance renewal coming up | Documentation may matter | Check continuation rules before your next refill |
| Cash cost is too high | Brand, dose, or provider may need a rethink | Compare your cost options before you run out |
| On Medicare, locked out before | A $50/month path may now exist | See if you qualify for the new Medicare GLP-1 Bridge |
| Needle-averse | A pill option may fit | Ask about the Wegovy pill or Foundayo -- don't assume equal doses |
| Using a compounded product | Dose clarity matters more here | Confirm strength, units, and pharmacy |
How we built this guide
We separated three kinds of facts on purpose: medical facts, money facts, and our own opinions. Medical and dosing claims come from official labels, FDA communications, manufacturer dosing pages, insurer policies, and published clinical trials. Anything that's our judgment is clearly our editorial view.
Our source order, strongest first:
- FDA labels and official prescribing information (and DailyMed)
- Manufacturer dosing pages
- FDA safety communications and CMS coverage pages
- Peer-reviewed clinical trials (STEP 1, SURMOUNT-4, SURMOUNT-MAINTAIN)
- Insurance and payer policy documents
- Provider websites and pricing pages
Medical dosing and safety sources last checked . Provider pricing, coverage, and formulary details change without notice.
The questions everyone asks heading into maintenance
Across weight-loss communities, the same worries come up again and again. These aren't testimonials, medical advice, or proof of any typical result — they're here to show you the worry is normal.
- "I'm a few pounds from my goal and suddenly thinking about maintenance. How do people handle this?"
- "For anyone in maintenance or tapering -- how much do you actually trust your own habits to keep it off?"
- "I kind of assumed I'd be on this for life. Is that really how it works?"
GLP-1 maintenance dose: frequently asked questions
- Is there one standard GLP-1 maintenance dose?
- No. The maintenance dose depends on the medication, the FDA label, your response, what you can tolerate, and your prescriber's plan. A Wegovy maintenance dose is not the same as a Zepbound, Foundayo, or Saxenda maintenance dose.
- Is 2.5 mg Zepbound a maintenance dose?
- No. Zepbound 2.5 mg is the starter dose and is not approved as a maintenance dose. The approved maintenance doses for weight management are 5 mg, 10 mg, or 15 mg once a week.
- Is 0.25 mg Wegovy a maintenance dose?
- No. Wegovy pen 0.25 mg is a starter dose used while you build up. The Wegovy pen maintenance doses are 1.7 mg or 2.4 mg a week, with a higher 7.2 mg dose available for certain adults who tolerate 2.4 mg and need more.
- Is 1.7 mg Wegovy a maintenance dose?
- Yes. The Wegovy pen has two approved maintenance doses, 1.7 mg and 2.4 mg once weekly. The right one depends on how you tolerate it and how you're responding.
- What is the Wegovy pill maintenance dose?
- The Wegovy pill maintenance dose is 25 mg once a day. Take it in the morning on an empty stomach with water up to 4 ounces, and wait at least 30 minutes before eating, drinking, or taking other medicine.
- What is the Foundayo maintenance dose?
- Foundayo starts at 0.8 mg a day and steps up about every 30 days to a maintenance dose of 5.5, 9, 14.5, or 17.2 mg once daily, based on response and tolerability. The maximum is 17.2 mg -- or 9 mg if you take a strong CYP3A4 inhibitor. It can be taken any time of day, with or without food.
- Do you have to stay on a GLP-1 forever?
- Not necessarily, but many people need a long-term maintenance plan because weight regain is common after stopping. Trials of semaglutide and tirzepatide show most people regain a large share of their lost weight after they stop. Whether you stay on it is a decision to make with your prescriber.
- Can you microdose a GLP-1 for maintenance?
- Some clinicians may discuss a lower maintenance dose, but self-directed microdosing is not the same as a label-based plan. With compounded products especially, this is risky, because the FDA has warned about dosing mistakes. Talk to your prescriber before going below a standard dose.
- Can you switch from a shot to a pill for maintenance?
- Possibly, but only with your prescriber's guidance. Pills and shots have different doses, schedules, and timing rules, so the doses can't be swapped one-for-one.
- What should I do if food noise comes back during maintenance?
- Note when it returns and whether it lines up with your dose timing, sleep, stress, or a missed dose -- then bring that pattern to your prescriber. Food noise returning doesn't mean you failed; it's a useful sign that your plan may need a tune-up.
Sources
- Wegovy (semaglutide) pen and tablet -- Prescribing Information and dosing pages, Novo Nordisk; FDA label (accessdata.fda.gov); Wegovy HD 7.2 mg approved March 2026; Wegovy tablets approved December 2025.
- Zepbound (tirzepatide) -- Prescribing Information and dosing, Eli Lilly; FDA label; Drugs.com Zepbound dosage (updated April 2026).
- Foundayo (orforglipron) -- Prescribing Information and dosing, Eli Lilly; FDA label and DailyMed (CYP3A4 9 mg limit, oral-contraceptive interaction, missed-dose rule); FDA approval April 1, 2026.
- Saxenda (liraglutide) -- saxenda.com dosing; FDA label.
- Ozempic injection and Ozempic pill (oral semaglutide), and Rybelsus -- manufacturer prescribing information; Pharmacy Times (Ozempic pill nationwide launch May 4, 2026, replacing Rybelsus).
- Mounjaro (tirzepatide) -- manufacturer prescribing information (diabetes indication).
- FDA -- dosing errors associated with compounded injectable semaglutide products; FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (salt forms; compounded drugs not FDA-reviewed).
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022.
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA, 2024.
- Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). The Lancet, published online May 12, 2026.
- Insurance -- Aetna Wegovy prior-authorization criteria; Cigna National Formulary GLP-1 policy (2026); CVS Caremark plan policies; California Medi-Cal Rx GLP-1 Coverage Considerations (effective Jan 1, 2026).
- Medicare GLP-1 Bridge -- CMS press release and program pages ($50/month, July 1, 2026-Dec 31, 2027); KFF program summary.
Still not sure which GLP-1 program is right for you?
Answer a few quick questions about your medication, dose, insurance, budget, and biggest maintenance worry. We'll point you toward the safest next step to discuss with a licensed provider.
Get your personalized GLP-1 action plan →Or check your coverage now — free with Ro → (sponsored affiliate link, opens in a new tab)Affiliate disclosure
The RX Index may earn a commission if you use some of the provider links on this page. That never changes our dosing guidance, which comes straight from official labels, FDA communications, payer policies, and published studies.Related guides from The RX Index
- Best GLP-1 for long-term maintenance
- GLP-1 cost without insurance: 17 real prices
- Cheapest Zepbound without insurance
- Foundayo cost without insurance
- Wegovy pill cost without insurance
- Best GLP-1 providers that accept insurance
- Best GLP-1 providers that help with prior authorization
- Does Medicare cover Foundayo?
- Does the Medicare GLP-1 Bridge cover the Wegovy pill?
- Free 60-second GLP-1 matching quiz